Answers are grounded in this paper and cite their sources.
OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of tolvaptan versus standard medical management, placebo, or other vaptans for the treatment of hyponatraemia in people with cirrhosis.
No takes yet. Share an insight, caveat, or question.
Anila et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: